Transcat Overview
- Year Founded
-
1964
- Status
-
Public
- Employees
-
1,413
- Stock Symbol
-
TRNS
- Investments
-
38
- Share Price
-
$93.02
- (As of Friday Closing)
Transcat General Information
Description
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.
Contact Information
Website
www.transcat.comCorporate Office
- 35 Vantage Point Drive
- Rochester, NY 14624
- United States
Corporate Office
- 35 Vantage Point Drive
- Rochester, NY 14624
- United States
Transcat Stock Performance
As of 20-Nov-2026, Transcat’s stock price is $93.02. Its current market cap is $874M with 9.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $93.02 | $97.53 | $50.23 - $112.44 | $874M | 9.4M | 141K | $0.49 |
Transcat Financials Summary
As of 30-Sep-2026, Transcat has a trailing 12-month revenue of $363M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 964,135 | 815,979 | 754,467 | 970,687 |
| Revenue | 363,216 | 331,877 | 278,421 | 259,481 |
| EBITDA | 40,670 | 38,740 | 36,866 | 33,010 |
| Net Income | 4,590 | 5,376 | 14,515 | 13,647 |
| Total Assets | 507,056 | 480,487 | 385,242 | 287,552 |
| Total Debt | 150,953 | 133,262 | 57,727 | 21,539 |
Transcat Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Transcat Comparisons
Industry
Financing
Details
Transcat Competitors (14)
One of Transcat’s 14 competitors is SIKA Dr. Siebert & Kühn, a Corporation company based in Kaufungen, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SIKA Dr. Siebert & Kühn | Corporation | Kaufungen, Germany | ||||
| Senseca UK | Private Equity-Backed | Bristol, United Kingdom | ||||
| RIGOL Technology | Formerly PE-Backed | Suzhou, China | ||||
| Resources For Manufacturing | Private Debt Financed | Miamisburg, OH | ||||
| Autometer Meß- Und Automatisierungstechnik | Corporation | Siegen, Germany |
Transcat Patents
Transcat Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2631083-A1 | Metrology methods | Inactive | 11-May-2007 | ||
| US-20080278493-A1 | Metrology methods | Inactive | 11-May-2007 | ||
| WO-2002015109-A1 | Pda instrument/process calibrator | Inactive | 14-Aug-2000 | ||
| WO-2002015109-A9 | Pda instrument/process calibrator | Inactive | 14-Aug-2000 | ||
| US-4591796-A | Performance predictable linearizing or function modifying circuit | Inactive | 26-Mar-1984 | H03G7/005 |
Transcat Signals
Transcat Acquisitions (38)
Transcat’s most recent deal was a Merger/Acquisition with Southeastern Biomedical Associates for . The deal was made on 31-Aug-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Southeastern Biomedical Associates | 31-Aug-2026 | Merger/Acquisition | Distributors (Healthcare) | ||
| SCM Metrology and Laboratories | 09-Apr-2026 | Merger/Acquisition | Other Commercial Services | ||
| Essco Calibration Laboratory | 05-Aug-2025 | Merger/Acquisition | Electronic Equipment and Instruments | ||
| Martin Calibration | 10-Dec-2024 | Merger/Acquisition | Other Commercial Services | ||
| Becnel Rental Tools | 15-Apr-2024 | Merger/Acquisition | Specialty Retail |
Transcat ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
22.04 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Commercial Services
Industry
of 335
Rank
Percentile
Research and Consulting
Subindustry
of 58
Rank
Percentile
Transcat Exits (2)
Transcat’s most recent exit was on 12-Jun-2018 from NBS Calibrations. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| NBS Calibrations | 12-Jun-2018 | Completed |
|
||
| United Scale & Engineering | 27-Jan-2010 | Merger/Acquisition | Completed |
Transcat Affiliates
Subsidiaries (10)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| NEXA Enterprise Asset Management | Doylestown, PA | 2015 | |
| Becnel Rental Tools | Gray, LA | 2012 | |
| Anmar Acquisition | Rochester, NY | 2012 | |
| Laboratoire Dispersion | Montreal, Canada | 2009 | |
| Axiom Test Equipment | Vista, CA | 2005 |
Transcat FAQs
-
When was Transcat founded?
Transcat was founded in 1964.
-
Where is Transcat headquartered?
Transcat is headquartered in Rochester, NY.
-
What is the size of Transcat?
Transcat has 1,413 total employees.
-
What industry is Transcat in?
Transcat’s primary industry is Electronic Equipment and Instruments.
-
Is Transcat a private or public company?
Transcat is a Public company.
-
What is Transcat’s stock symbol?
The ticker symbol for Transcat is TRNS.
-
What is the current stock price of Transcat?
As of 20-Nov-2026 the stock price of Transcat is $93.02.
-
What is the current market cap of Transcat?
The current market capitalization of Transcat is $874M.
-
What is Transcat’s current revenue?
The trailing twelve month revenue for Transcat is $363M.
-
Who are Transcat’s competitors?
SIKA Dr. Siebert & Kühn, Senseca UK, RIGOL Technology, Resources For Manufacturing, and Autometer Meß- Und Automatisierungstechnik are some of the 14 competitors of Transcat.
-
What is Transcat’s annual earnings per share (EPS)?
Transcat’s EPS for 12 months was $0.49.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process